Supriya Lifescience Ltd share price logo

Supriya Lifescience Share Price

NSE: SUPRIYA

BSE: 543434

Small Cap

Healthcare Sector

₹693.25

+27.75

(+4.17%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Supriya Lifescience Stock Performance

as on February 3, 2026 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹673.40
    ₹699.95
    downward going graph

    2.86%

    Downside

    0.97%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹556.15
    ₹842.00
    downward going graph

    19.78%

    Downside

    21.46%

    Upside

    downward going graph

Supriya Lifescience share price movements today

Previous Close
₹665.50
Open
₹691.75
Volume
1.58L
Upper Circuit
₹798.60
Lower Circuit
₹532.40
Day's Low - High
₹673.40 - ₹699.95
52 Week Low - High
₹556.15 - ₹842.00

Supriya Lifescience Historical Returns

1 Month Return
-10.64 %
3 Month Return
-15.22 %
1 Year Return
-5.01 %
3 Year Return
+ 235.94 %
5 Year Return
+ 70.27 %

Supriya Lifescience Fundamentals

as on February 3, 2026 at 4:01 pm IST

Market Cap

₹5,356.13 Cr

Return on Equity (ROE)

20.74

PE Ratio (TTM)

0

Return on capital employed (ROCE)

27.43

Beta (LTM)

1.55

P/B Ratio

5.92

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

9.27

EPS (TTM)

0

Sector

Pharmaceuticals

Book Value

0

Technical Analysis

Bearish

View Technical Analysis

Supriya Lifescience Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Supriya Lifescience with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Supriya Lifescience Ltd image
Supriya Lifescience Ltd
BUY5,356.1314.05%0.00187696
Walpar Nutritions Ltd image
Walpar Nutritions Ltd
NA42.7311.93%0.69271
Orchid Pharma Ltd image
Orchid Pharma Ltd
BUY3,419.7415.73%0.5695921
Brawn Biotech Ltd image
Brawn Biotech Ltd
NA5.78-3.51%0.00-213
Medicamen Biotech Ltd image
Medicamen Biotech Ltd
NA489.89-6.91%0.576162
See all

Analyst Recommendation on Supriya Lifescience Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Supriya Lifescience. Average target price of ₹940

Source: S&P Global Market Intelligence

Supriya Lifescience Share Price Target

Get share price movements and forecasts by analysts on Supriya Lifescience.

What analysts predicted

41.25%UPSIDE

Target Price

₹940

Current Price

₹693.25

Analyzed by

2 Analysts

High

₹1030

Target

₹940.00

Low

₹850

Supriya Lifescience target price ₹940, a slight upside of 41.25% compared to current price of ₹693.25. According to 2 analysts rating.

Source: S&P Global Market Intelligence

Supriya Lifescience Stock’s Investor Sentiment and Interest

Search interest for Supriya Lifescience Ltd Stock has increased by 6% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:6% versus previous 30 day period

Supriya Lifescience Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Sales
142.27
132.02
140.1
140.07
158.18
160.63
166.1
185.65
184.11
145.07
199.83
Other Income
1.96
2.92
2.47
3.07
2.19
2.22
2.52
2.1
2.98
2.67
2.73
Total Income
144.23
134.94
142.56
143.14
160.37
162.85
168.62
187.75
187.08
147.75
202.56
Expenses
87.22
87.79
108.34
98.59
102.68
98.09
101.39
119.7
116.53
93.37
127.19
Operating Profit
55.05
44.23
31.76
41.48
55.5
62.54
64.71
65.95
67.58
51.7
72.64
Operating Profit Margin %
38.69%
33.5%
22.67%
29.61%
35.09%
38.93%
38.96%
35.52%
36.71%
35.64%
36.35%
Profit Before Interest, Tax and Depreciation
57.01
47.15
34.22
44.55
57.69
64.77
67.24
68.05
70.56
54.38
75.37
Interest
0.71
0.56
0.46
0.49
0.6
0.34
0.43
0.51
0.42
0.51
0.42
Depreciation
3.01
3.96
3.98
3.96
3.91
4.66
4.74
4.96
6.08
6.45
6.64
Profit Before Tax
53.29
42.63
29.78
40.1
53.18
59.77
62.07
62.58
64.06
47.42
68.31
Tax Paid
15.06
14.12
5.9
10.32
16.24
15.13
15.92
15.8
13.68
12.63
17.89
Profit After Tax
38.23
28.51
23.88
29.79
36.93
44.64
46.15
46.78
50.38
34.79
50.43
Total Net profit including share of profit / Loss from associate company
38.23
28.51
23.88
29.79
36.93
44.64
46.15
46.78
50.38
34.79
50.43
EPS
4.75
3.54
2.97
3.7
4.59
5.54
5.71
5.82
6.29
4.32
6.27
Actual EPS
4.75
3.54
2.97
3.7
4.59
5.54
5.71
5.82
6.29
4.32
6.27
Adjusted EPS
4.75
3.54
2.97
3.7
4.59
5.54
5.71
5.82
6.29
4.32
6.27
Diluted EPS
4.75
3.54
2.97
3.7
4.59
5.54
5.71
5.82
6.29
4.32
6.27

Supriya Lifescience Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
212.91
277.84
311.64
391.25
530.05
460.94
570.37
696.49
Other Income
8.6
8.02
11.07
4.98
7.58
9.49
10.64
9.82
Total Income
221.51
285.86
322.71
396.22
537.63
470.43
581.01
706.3
Expenses
190.96
213.1
213.26
218.07
316.06
332.04
397.39
435.69
Operating Profit
21.95
64.74
98.38
173.18
213.99
128.9
172.98
260.8
Operating Profit Margin %
10.31%
23.3%
31.57%
44.26%
40.37%
27.96%
30.33%
37.44%
Profit Before Interest, Tax and Depreciation
30.55
72.76
109.45
178.15
221.56
138.39
183.61
270.61
Interest
10.75
10.22
6.85
4.08
4.2
3.08
2.11
1.69
Depreciation
5.33
5.44
6.41
6.76
10.12
11.82
15.81
20.44
Profit Before Tax
14.47
57.1
96.19
167.31
207.24
123.49
165.69
248.48
Tax Paid
5.74
17.68
22.82
43.72
55.44
33.63
46.58
60.53
Profit After Tax
8.73
39.42
73.37
123.59
151.81
89.86
119.11
187.96
Total Net profit including share of profit / Loss from associate company
8.73
39.42
73.37
123.59
151.81
89.86
119.11
187.96
EPS
1.19
5.39
10.03
16.89
18.86
11.16
14.8
23.35
Actual EPS
1.19
5.39
10.03
16.89
18.86
11.16
14.8
23.35
Adjusted EPS
1.19
5.39
2.01
16.89
18.86
11.16
14.8
23.35
Diluted EPS
1.19
5.39
10.03
16.89
18.86
11.16
14.8
23.35

Supriya Lifescience Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
13.5
27.34
27.76
48.88
116.67
75.89
48.8
63.61
113.31
164.68
Cash Flow from Investing Activities
-32.83
-8.57
-4.71
4.83
-25.14
-46.8
-59.82
-123.65
-173.57
-152.24
Cash Flow from Financing Activities
21.36
-2.25
-20.01
-49.92
-29.24
-14.51
149.65
-10.28
-22.36
-8.24
Net Cash Flow
2.03
-1.51
3.03
3.79
62.31
14.57
138.63
-70.33
-82.63
4.2

Supriya Lifescience Stock Shareholding Pattern

Numbers in percentages

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Promoters
68.28%
68.3%
68.3%
68.3%
68.3%
68.3%
68.3%
68.3%
68.3%
68.3%
68.3%
68.3%
DII
7.65%
7.55%
7.17%
3.85%
5.3%
5.48%
5.45%
4.92%
4.26%
4.86%
5.22%
5.01%
FII
0%
0%
5.34%
0%
5.36%
4.95%
6.03%
6.52%
7.19%
6.78%
5.46%
5.2%
Public
18.42%
18.43%
19.19%
21.76%
21.04%
21.27%
20.23%
20.26%
20.26%
20.06%
21.02%
21.5%
Total Outstanding Shares
8,04,82,800
8,04,82,800
8,04,82,800
8,04,82,800
8,04,82,800
8,04,82,800
8,04,82,800
8,04,82,800
8,04,82,800
8,04,82,800
8,04,82,800
8,04,82,800
Total Shareholders
95,605
93,478
92,991
95,929
87,980
89,621
85,328
89,394
91,051
91,928
87,912
85,099

Mutual Funds that own Supriya Lifescience Stock

Check out the Mutual Funds with significant holdings in Supriya Lifescience.

Supriya Lifescience Corporate Actions

View detailed summary of the earnings and dividend history of Supriya Lifescience.

  • Supriya Lifescience Ltd Earnings Results

    Supriya Lifescience Ltd’s net profit jumped 9.27% since last year same period to ₹50.43Cr in the Q2 2025-2026. On a quarterly growth basis, Supriya Lifescience Ltd has generated 44.96% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Supriya Lifescience Ltd Dividends May,2025

    In the quarter ending March 2025, Supriya Lifescience Ltd has declared dividend of ₹1.00 per share on 27 May 2025 - translating a dividend yield of 0.27%.

    Read More about Dividends

Indices Featuring Supriya Lifescience Stock

Check stock indices that include Supriya Lifescience.

BSE Healthcare

₹42,253.02

2.83 (▲1164.07%)

Insights on Supriya Lifescience Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 years, SUPRIYA stock has moved up by 235.9%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, SUPRIYA has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 20.06% to 21.02% in Sep 2025 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 68.30% of holdings in Sep 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 25.8% return, outperforming this stock by 30.8%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 6.78% to 5.46% in Sep 2025 quarter

About Supriya Lifescience Ltd

Supriya Lifescience Limited is an Indian manufacturing company and supplier of active pharmaceutical ingredients (APIs). As of 31 March 2021, the company has offered 39 APIs with a focus on therapeutic segments such as antihistamines, analgesics, anaesthetics, vitamins, anti-asthmatics and anti-allergies. The company has consistently been the largest exporter of Chlorpheniramine Maleate and Ketamine Hydrochloride from India - 4555 and 6570 units, respectively - between Fiscal 2017 and 2020. Supriya Lifescience has sought approval for its products from international regulatory authorities including the USFDA, EUGMP and EDQM, and is supported by a modern manufacturing facility. Two new clean rooms are set to be powered up in the first quarter of Fiscal 2022. Over the years, the company has issued 3002400, 1626302, 9757804 Equity shares and increased its face value from Rs 10 to Rs 2 per share. In December 2021, Supriya Lifescience Limited conducted a Rs 700 crores public issue and the allotted shares were listed on BSE Ltd and NSE.

Revenue: ₹199.83Cr as on September 2025 (Q2 FY26)
Net Profit: ₹50.43Cr as on September 2025 (Q2 FY26)
Listing date: 28 Dec, 2021
Chairperson Name: Satish Waman Wagh
OrganisationSupriya Lifescience Ltd
IndustryPharmaceuticals
CEOSatish Waman Wagh
E-voting on sharesClick here to vote

FAQs

What is Supriya Lifescience share price today?

Supriya Lifescience share price today stands at ₹693.25 as on at the close of the market. Supriya Lifescience share today touched a day high of ₹699.95 and a low of ₹673.4.

What is the 52 week high and 52 week low range for Supriya Lifescience share?

Supriya Lifescience touched a 52 week high of ₹842 and a 52 week low of ₹556.15. Supriya Lifescience share price today i.e. is closed at ₹693.25, which is -17.67% down from its 52 week high and 24.65% up from its 52 week low.

What is Supriya Lifescience's market capitalisation today?

Supriya Lifescience market capitalisation is ₹5,356.13 Cr as on .

How to buy Supriya Lifescience shares?

To buy Supriya Lifescience shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for SUPRIYA or Supriya Lifescience Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Supriya Lifescience shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Supriya Lifescience trading volume today?

Supriya Lifescience trading volume is 1.58L as on . This means that 1.58L shares of Supriya Lifescience were bought and sold on the stock market during today's trading session.